Noack, J. H. G. (2013). Combining a sphingosine kinase inhibitor with temozolomide synergistically increases glioblastoma cell death: Mechanism and clinical relevance.
Chicago Style (17th ed.) CitationNoack, Johannes Hans Günther. Combining a Sphingosine Kinase Inhibitor with Temozolomide Synergistically Increases Glioblastoma Cell Death: Mechanism and Clinical Relevance. 2013.
MLA (9th ed.) CitationNoack, Johannes Hans Günther. Combining a Sphingosine Kinase Inhibitor with Temozolomide Synergistically Increases Glioblastoma Cell Death: Mechanism and Clinical Relevance. 2013.
Warning: These citations may not always be 100% accurate.